Search Results - "Maina, A M"

Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases by Coco, B., Oliveri, F., Maina, A. M., Ciccorossi, P., Sacco, R., Colombatto, P., Bonino, F., Brunetto, M. R.

“…Liver stiffness was measured by transient elastography (FibroScan®) in 228 consecutive patients with chronic viral hepatitis, with (115) or without cirrhosis…”
Get full text

Early and Accurate Prediction of Peg-IFNs/Ribavirin Therapy Outcome in the Individual Patient With Chronic Hepatitis C by Modeling the Dynamics of the Infected Cells by Colombatto, P, Ciccorossi, P, Maina, AM, Civitano, L, Oliveri, F, Coco, B, Romagnoli, V, Bonino, F, Brunetto, MR

“…A novel biomathematical model that analyzes the combined alanine transaminase (ALT) and viral‐load kinetics during the first month of pegylated interferon…”
Get full text

Emergence of hepatitis B virus quasispecies with lower susceptibility to nucleos(t)ide analogues during lamivudine treatment by Moriconi, F., Colombatto, P., Coco, B., Ciccorossi, P., Oliveri, F., Flichman, D., Maina, A. M., Sacco, R., Bonino, F., Brunetto, M. R.

“…Objectives We studied the impact of hepatitis B virus (HBV) polymerase/reverse transcriptase (Pol/Rt) heterogeneity on adefovir rescue therapy in 34…”
Get full text

Clinical and molecular characterization of chronic hepatitis B in Albania: A country that is still highly endemic for HBV infection by Kondili, L.A., Brunetto, M.R., Maina, A.M., Argentini, C., Chionne, P., La Sorsa, V., Resuli, B., Mele, A., Rapicetta, Maria

“…Albania is a Mediterranean country, still with a high endemicity level of hepatitis B virus (HBV) infection. The chronic hepatitis B profile was characterized…”
Get full text

HCV E1E2-MF59 vaccine in chronic hepatitis C patients treated with PEG-IFNα2a and Ribavirin: a randomized controlled trial by Colombatto, P., Brunetto, M. R., Maina, A. M., Romagnoli, V., Almasio, P., Rumi, M. G., Ascione, A., Pinzello, G., Mondelli, M., Muratori, L., Rappuoli, R., Rosa, D., Houghton, M., Abrignani, S., Bonino, F.

“…Summary Hepatitis C virus (HCV) vaccines may be able to increase viral clearance in combination with antiviral therapy. We analysed viral dynamics and…”
Get full text

HCV E1E2-MF59 vaccine in chronic hepatitis C patients treated with PEG-IFN alpha 2a and Ribavirin: a randomized controlled trial by Colombatto, P, Brunetto, M R, Maina, A M, Romagnoli, V, Almasio, P, Rumi, M G, Ascione, A, Pinzello, G, Mondelli, M, Muratori, L, Rappuoli, R, Rosa, D, Houghton, M, Abrignani, S, Bonino, F

“…Hepatitis C virus (HCV) vaccines may be able to increase viral clearance in combination with antiviral therapy. We analysed viral dynamics and HCV-specific…”
Get full text

Diagnosis and monitoring of hepatitis virus infection in liver transplant patients by Maina, A.M, Ciccorossi, P, Oliveri, F, Filipponi, F, Brunetto, M.R

Get full text

Influence of different levels of ammonium concentrations on cell growth, RNA and protein production by Candida albicans by VIDOTTO, V, BENECH, S, MAINA, A. M, BRUATTO, M

“…Candida albicans starved cells were incubated in minimal synthetic liquid media containing different concentrations of ammonium sulphate (0.00, 0.02, 0.05,…”
Get full text

Growth of Cryptococcus neoformans in a thiamine-free medium by BRUATTO, M, VIDOTTO, V, MAINA, A. M

“…The growth of Cryptococcus neoformans in a minimal liquid synthetic medium with or without thiamine (10 micrograms/ml) was investigated. In these media the…”
Get full text

Anti-neutrophil cytoplasmic antibodies in inflammatory bowel disease: do they recognize different subsets of a heterogeneous disease? by Castellino, F, Rosina, F, Bansi, D S, Bauducci, M, Touscoz, G A, Giorda, L, Borghesio, E, Bessone, M P, Astegiano, M, Musso, A

“…To evaluate the prevalence of anti-neutrophil cytoplasmic antibodies in a series of patients with inflammatory bowel disease, the discriminatory value of these…”
Get more information

HCV E1E 2‐ MF 59 vaccine in chronic hepatitis C patients treated with PEG ‐ IFN α2a and R ibavirin: a randomized controlled trial by Colombatto, P., Brunetto, M. R., Maina, A. M., Romagnoli, V., Almasio, P., Rumi, M. G., Ascione, A., Pinzello, G., Mondelli, M., Muratori, L., Rappuoli, R., Rosa, D., Houghton, M., Abrignani, S., Bonino, F.

“…Summary Hepatitis C virus ( HCV ) vaccines may be able to increase viral clearance in combination with antiviral therapy. We analysed viral dynamics and HCV…”
Get full text

HCV E1E2-MF59 vaccine in chronic hepatitis C patients treated with PEG-IFN[alpha]2a and Ribavirin: a randomized controlled trial by Colombatto, P, Brunetto, M R, Maina, A M, Romagnoli, V, Almasio, P, Rumi, M G, Ascione, A, Pinzello, G, Mondelli, M, Muratori, L, Rappuoli, R, Rosa, D, Houghton, M, Abrignani, S, Bonino, F

“…Summary Hepatitis C virus (HCV) vaccines may be able to increase viral clearance in combination with antiviral therapy. We analysed viral dynamics and…”
Get full text

Longitudinal evaluation reveals a complex spectrum of virological profiles in hepatitis B virus/hepatitis C virus-coinfected patients by RAIMONDO, Giovanni, BRUNETTO, Maurizia R, PONTISSO, Patrizia, SMEDILE, Antonina, MAINA, Anna Maria, SAITTA, Carlo, SQUADRITO, Giovanni, TONO, Natascia

“…Hepatitis B virus (HBV) and hepatitis C virus (HCV) coinfection is often associated with severe forms of liver disease. However, comprehensive studies are…”
Get full text

Impact Assessment of a Behavior Change Communication Program in Niger by Horii, Naoko, MPH, MA, Habi, O., MS, Dangana, A., MS, Maina, A., MS, Alzouma, S., MS

Get full text

Behavior of Candida albicans during a period of nutritional deprivation. Preliminary results by Bruatto, M, Olivero, M T, Perotti, D, Maina, A M, Bugnone, C, Benech, S

“…Cells of Candida albicans, after 24 hours of growth in YM, were starved, alternatively, in citrate buffer, physiological solution, MMS deprived of glucose or…”
Get more information